PremiumThe FlyBayer says FDA accepts NDA under priority review for sevabertinib Bayer price target raised to EUR 25 from EUR 22 at Barclays Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones PremiumThe FlyUnitedHealth suspends outlook, Under Armour reports Q4 beat; Morning Buzz Bayer sees FY25 sales EUR 45B-EUR 47B on currency-adjusted basis Bayer confirms mid-term ambition for Crop Science PremiumThe FlyBayer’s treatment of Alport syndrome granted FDA orphan designation Bayer price target lowered to EUR 20 from EUR 22 at HSBC Freight Technologies integrates with Blue Yonder’s TMS through Bayer 
